Literature DB >> 29984726

Risk factors for poor visual outcome in traumatic hyphema: Jakarta eye trauma study.

G W S Simanjuntak1, G Farinthska2, G A M Simanjuntak2, W Artini3, R Natali2.   

Abstract

OBJECTIVE: : To report the risk factors for poor visual outcome in traumatic hyphema.
MATERIALS AND METHODS: A retrospective study was done by collecting data from medical records between January 2011 and December 2015 in Jakarta, Indonesia. Clinical data included initial visual acuity (IVA), final VA at 3 months, slit lamp evaluation with grading of hyphema, intraocular pressure, and fundus findings on direct or indirect ophthalmoscopy.
RESULTS: The study included 97 patients, with males showing a preponderance, the ratio being 9:1. Soft gun pellet was the most common cause (27.8%), others being workplace injuries (12.4%), sports injury (14.4%), traffic accident (2.1%), and other injuries (43.3%). Poor visual outcome was due to vitreous hemorrhage, cataract, iridodialysis, and choroidal rupture. On statistical analysis, significant risk factors were causality (P = 0.018), IVA (P = 0.026), onset of injury (0.000), and grade of hyphema (P = 0.000).
CONCLUSION: Grade of hyphema, IVA, causality, and onset of injury were significant risk factors related to poor visual outcome in traumatic hyphema.

Entities:  

Keywords:  Cause of injury; hyphema; intraocular pressure; paracentesis; risk factor

Mesh:

Year:  2018        PMID: 29984726     DOI: 10.4103/njcp.njcp_251_17

Source DB:  PubMed          Journal:  Niger J Clin Pract            Impact factor:   0.968


  2 in total

1.  Traumatic Iridodialysis Associated With Hyphema Secondary to Injury From a Bungee Cord.

Authors:  Woo Kyung Lee; Sumeja Aljic; Patrick Barry; Latha Ganti
Journal:  Cureus       Date:  2021-02-11

2.  Clinical features, management and visual outcomes on patients with traumatic hyphema in a reference ophthalmological clinic in Colombia.

Authors:  Virgilio Galvis; Angelica Pedraza-Concha; Alejandro Tello; M Lina Plata; C Luis Escaf; D Ruben Berrospi
Journal:  Rom J Ophthalmol       Date:  2020 Jan-Mar
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.